Your browser doesn't support javascript.
loading
A Novel P53 Nanomedicine Reduces Immunosuppression and Augments Anti-PD-1 Therapy for Non-Small Cell Lung Cancer in Syngeneic Mouse Models.
Kim, Sang-Soo; Harford, Joe B; Moghe, Manish; Doherty, Caroline; Chang, Esther H.
Affiliation
  • Kim SS; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC 20057, USA.
  • Harford JB; SynerGene Therapeutics, Inc., Potomac, MD 20854, USA.
  • Moghe M; SynerGene Therapeutics, Inc., Potomac, MD 20854, USA.
  • Doherty C; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC 20057, USA.
  • Chang EH; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC 20057, USA.
Cells ; 11(21)2022 10 31.
Article in En | MEDLINE | ID: mdl-36359830
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms / Antineoplastic Agents Limits: Animals Language: En Journal: Cells Year: 2022 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms / Antineoplastic Agents Limits: Animals Language: En Journal: Cells Year: 2022 Document type: Article Affiliation country: Country of publication: